Overview

Long-term Better Than Short-term ADT With Salvage RT

Status:
Not yet recruiting
Trial end date:
2029-02-01
Target enrollment:
Participant gender:
Summary
A randomized, multicenter, prospective PHASE II trial to assess the effect of short- versus long-term adjuvant ADT with high dose salvage radiotherapy on distant metastasis free survival in case of biochemical relapse (BR) after radical prostatectomy.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Universitaire Ziekenhuizen Leuven
Collaborator:
Ipsen
Treatments:
Triptorelin Pamoate